Clinical and Economic Impact of Teleneurology vs Standard in Clinic Care for Multiple Sclerosis: A Randomized Trial
远程神经学与多发性硬化症临床护理标准的临床和经济影响:随机试验
基本信息
- 批准号:10583096
- 负责人:
- 金额:$ 56.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-26 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AcademyAcheAddressAdherenceAdultAffectAmericanAutomobile DrivingCOVID-19 pandemicCaliforniaCaregiver BurdenCaringChronicClinicClinic VisitsClinicalCommunitiesComprehensive Health CareCost Effectiveness AnalysisDataDiagnosisDirect CostsDiseaseDropoutEmergency department visitEnrollmentEnsureEvaluationFaceFacilities and Administrative CostsGeneral PopulationGoalsHealthHealth Care CostsHealth Services AccessibilityHealthcareHomeHospitalizationImmuneImprove AccessInterventionInterviewKnowledgeMediatingMedicalMethodologyMethodsModalityModelingMultiple SclerosisNeurologistNeurologyNewly DiagnosedOutcomeOutpatientsParticipantPatient Care TeamPatient Outcomes AssessmentsPatientsPatterns of CarePerceptionPersonsPharmaceutical PreparationsPoliciesPopulationPositioning AttributeProceduresProductivityProviderQuality-Adjusted Life YearsRandomizedRandomized Clinical TrialsRecommendationRegulationResearchResourcesSamplingSan FranciscoSavingsScheduleSecureServicesSiteSpecialized CenterStandardizationSurveysTestingTimeTravelUniversitiesVisitWorkarmbasecare costscare deliverycentral nervous system demyelinating disorderclinical careclinical trial participantcostdesigndigitaldisabilityeconomic impactexperiencefollow-uphealth care deliveryhealth care service utilizationhealth related quality of lifehospitalization ratesimprovedinsightmultidisciplinarymultiple sclerosis patientnovelpilot trialpreferencerandomized trialsatisfactiontelehealthtelehealthcareteleneurologytheoriestwo-arm studyusability
项目摘要
PROJECT SUMMARY/ ABSTRACT
Multiple sclerosis (MS) patients have higher healthcare utilization, reduced work productivity, reduced quality-
adjusted life years, and lower health-related quality of life (QOL) relative to the general population. The current
standard of outpatient MS care depends on in-clinic visits, but MS patients face many barriers to accessing this
care. These barriers include those resulting from the disease itself, such as physical limitations, driving
restrictions and financial limitations, and they are further compounded by an overall shortage of neurologists.
Furthermore, MS care has a significant economic impact, with the estimated indirect and direct costs for treating
MS in the US estimated to be > $48 billion. Therefore, there is a need to improve access to and reduce cost of
MS care, and telehealth is a potential solution. Both our two multidisciplinary MS Centers (UCSF and Cleveland
Clinic) have demonstrated that telehealth for MS care is feasible and that it results in travel savings for patients,
reduction in missed work, and reduction in caregiver burden. Additionally, patient and provider satisfaction is
high for this modality of care at the time of care delivery. These initial results are promising, but to date there are
no studies assessing the longer-term impact of care delivery via telehealth on the Quadruple Aims of Healthcare:
clinical care, cost, patient experience and clinician experience.
The proposed study will directly bridge these research gaps in the longer-term impact of care delivery via
telehealth. We will complete a two-Center trial, randomizing newly diagnosed MS patients to receive their routine
MS care via telehealth or standard in-office care over 2 years. We will enroll 120 patients (assuming ~ 20%
dropout rate for 100 completers), and will assess and compare standard clinical outcomes, patient-reported
outcomes, costs, patient experience, and clinician care team experience associated with telehealth vs standard
in clinic care. We will also conduct exit interviews with purposefully sampled trial participants to better identify
facilitators and barriers to telehealth implementation. This study will generate needed evidence regarding the
impact of telehealth on clinical outcomes, its cost, and stakeholder experience, and will inform clinical care
implementation in other populations of MS patients and other chronic conditions.
项目摘要/摘要
多发性硬化症(MS)患者的医疗利用率更高,工作效率降低,质量下降-
调整后的寿命年数,与一般人口相比,与健康相关的生活质量(QOL)较低。海流
门诊多发性硬化症的标准取决于门诊就诊,但多发性硬化症患者在获得这一标准方面面临许多障碍
关心。这些障碍包括疾病本身造成的障碍,如身体限制、驾驶
这些限制和资金限制,再加上神经科医生的总体短缺,更是雪上加霜。
此外,多发性硬化症护理具有重大的经济影响,估计治疗的间接和直接成本
据估计,美国女性的身家为480亿美元。因此,有必要改善获取和降低成本。
MS CARE,远程医疗是一种潜在的解决方案。我们的两个多学科MS中心(加州大学旧金山分校和克利夫兰分校
临床)已经证明用于MS护理的远程医疗是可行的,并且它为患者节省了差旅,
减少缺勤,减轻照顾者负担。此外,患者和提供者的满意度是
在提供护理时,这种护理方式很高。这些初步结果是有希望的,但到目前为止,有
没有研究评估通过远程医疗提供的医疗服务对医疗保健四重目标的长期影响:
临床护理、成本、患者体验和临床医生体验。
拟议的研究将直接弥合这些研究在护理提供的长期影响方面的差距,通过
远程医疗。我们将完成一项双中心试验,随机选择新诊断的多发性硬化症患者接受常规治疗
2年以上通过远程医疗或标准办公室护理获得的MS护理。我们将招收120名患者(假设~20%
100名完成者的辍学率),并将评估和比较患者报告的标准临床结果
与远程医疗和标准医疗相关的结果、成本、患者体验和临床医生护理团队体验
在临床护理中。我们还将对有意抽样的试验参与者进行离职访谈,以更好地确定
远程保健实施的促进者和障碍。这项研究将产生关于
远程医疗对临床结果、成本和利益相关者体验的影响,并将为临床护理提供信息
在其他多发性硬化症患者和其他慢性疾病人群中实施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marisa McGinley其他文献
Marisa McGinley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marisa McGinley', 18)}}的其他基金
A Decision Support Tool for the Discontinuation of Disease Modifying Therapies in Multiple Sclerosis
停止多发性硬化症疾病修饰疗法的决策支持工具
- 批准号:
10739870 - 财政年份:2023
- 资助金额:
$ 56.91万 - 项目类别:
Clinical and Economic Impact of Teleneurology vs Standard in Clinic Care for Multiple Sclerosis: A Randomized Trial
远程神经学与多发性硬化症临床护理标准的临床和经济影响:随机试验
- 批准号:
10710059 - 财政年份:2022
- 资助金额:
$ 56.91万 - 项目类别:
相似国自然基金
转录因子BMAL1调控AChE在昼夜节律紊乱致认知损害中的作用及分子机制
- 批准号:2024Y9230
- 批准年份:2024
- 资助金额:15.0 万元
- 项目类别:省市级项目
基于无机基质固定碳点光学探针研究有机磷农药暴露AChE响应的活体测量
- 批准号:
- 批准年份:2024
- 资助金额:50 万元
- 项目类别:面上项目
基于AChE/NLRP3 靶点研究垂穗石松中抗AD新型黄酮苷
吐星酸酯类成分的发现及作用机制研究
- 批准号:2024JJ8138
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于GSK-3β/AChE双重抑制的抗AD杂交分子的设计、合成及作用机制研究
- 批准号:22367005
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
基于可逆界面传质调控机制的AChE固定化荧光传感器及有机磷农药高灵敏抗干扰速测
- 批准号:32372427
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
利用微流体技术合成富缺陷MOFs材料定向捕获AChE酶构筑高性能传感界面
- 批准号:32302225
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗基质干扰导向的AChE仿生荧光探针的设计合成及农药残留速测应用
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
基于高分辨活性轮廓分析的中药AChE/GSK3β双靶点抑制剂高内涵筛选研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新型AChE/NLRP3双靶点抑制剂—藤石松中抗AD新颖黄酮苷吐星酸酯类成分的发现及作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于AchE靶点的苗药三两银抗阿尔兹海默症甾体生物碱类化合物发现与作用机制研究
- 批准号:82260833
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
相似海外基金
AchE阻害活性アルカロイドの骨格生合成酵素の機能解析と改変
具有AchE抑制活性的生物碱骨架生物合成酶的功能分析及修饰
- 批准号:
23K24040 - 财政年份:2024
- 资助金额:
$ 56.91万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Research to create homoisoflavonoid analogues with both AChE inhibitory and neurite outgrowth promoting activities.
研究创建具有乙酰胆碱酯酶抑制和神经突生长促进活性的高异黄酮类似物。
- 批准号:
22K05458 - 财政年份:2022
- 资助金额:
$ 56.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AchE阻害活性アルカロイドの骨格生合成酵素の機能解析と改変
具有AchE抑制活性的生物碱骨架生物合成酶的功能分析及修饰
- 批准号:
22H02777 - 财政年份:2022
- 资助金额:
$ 56.91万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Exploring reversible AChE inhibitors as a treatment for refractory epilepsies
探索可逆的 AChE 抑制剂治疗难治性癫痫
- 批准号:
9764633 - 财政年份:2019
- 资助金额:
$ 56.91万 - 项目类别:
Towards continuous real-time acetylcholine esterase (AChE) monitoring using wearable sensors
使用可穿戴传感器进行连续实时乙酰胆碱酯酶 (AChE) 监测
- 批准号:
2520106 - 财政年份:2018
- 资助金额:
$ 56.91万 - 项目类别:
Studentship
GCAMP6 mice for determination of mechanisms of chronic muscle ache, pain and fatigue
GCAMP6 小鼠用于确定慢性肌肉疼痛、疼痛和疲劳的机制
- 批准号:
9090636 - 财政年份:2016
- 资助金额:
$ 56.91万 - 项目类别:
GCAMP6 mice for determination of mechanisms of chronic muscle ache, pain and fatigue
GCAMP6 小鼠用于确定慢性肌肉疼痛、疼痛和疲劳的机制
- 批准号:
9260952 - 财政年份:2016
- 资助金额:
$ 56.91万 - 项目类别:
Developing Cholinesterase (AChE) inhibitor screening methods using Nuclear Magnetic Resonance Spectroscopy (NMR)
使用核磁共振波谱 (NMR) 开发胆碱酯酶 (AChE) 抑制剂筛选方法
- 批准号:
1667863 - 财政年份:2015
- 资助金额:
$ 56.91万 - 项目类别:
Studentship
Accelerated AChE Reactivator Design by Mechanistic Neutron Scattering Studies
通过机械中子散射研究加速乙酰胆碱酯酶再激活器设计
- 批准号:
8735548 - 财政年份:2014
- 资助金额:
$ 56.91万 - 项目类别:
Accelerated AChE Reactivator Design by Mechanistic Neutron Scattering Studies
通过机械中子散射研究加速乙酰胆碱酯酶再激活器设计
- 批准号:
9632884 - 财政年份:2014
- 资助金额:
$ 56.91万 - 项目类别: